RAWSTOCKS Start trial

Home/Pricing

Pricing

One membership, two billing terms. Start on the seven-day trial and check the alerts against the record before you commit to anything.

Monthly
$99/ month
Starts with a 7-day trial at $7
  • Real-time alerts as positions are taken
  • QuantViper scanner suite
  • FlashPoint indicator
  • Live sessions and Sunday lessons
  • Full access to the alert record
  • Cancel any time · all sales final
Start the trial
Annual
$800/ year
$388 less than twelve months at the monthly rate
  • Everything in monthly
  • GammaEdge data service included
  • Premium chat and analyst DMs
  • Priority support
  • Rate locked for the term
  • Best value if you already know the desk
  • Non-refundable once the term begins
Go annual

What you are paying for

Access to a Discord where the desk posts the positions they are taking, in real time — plus the sessions, the scanner and the data that produce them. You are not buying a signal feed; you are buying a seat at a desk that publishes its losses alongside its wins.

Billing, cancellation and refunds

Rawstocks LLC is the seller of record. Whop provides the billing and access platform; card payments are processed by Stripe. We never see or store your card details.

All sales are final and subscription payments are non-refundable. Cancel from your Whop account at any time — cancelling stops future billing, and access continues to the end of the period you have already paid for. There is no partial refund or pro-rata credit for an unused portion, including on annual plans. Cancel inside the seven-day trial and you are not billed the monthly rate. This is exactly why the trial exists: evaluate the desk properly for $7 before committing to a full period. Full terms in the refund policy.

Risk disclosure

Trading options involves substantial risk of loss and is not suitable for every investor. Options can expire worthless. It is possible to lose the entire amount paid for a position in a single session.

Rawstocks LLC is a trading education and analysis community. We are not a registered investment adviser or broker-dealer, and nothing published here constitutes personalized investment advice. Past performance does not indicate future results. Read the full disclosure.